
|Poll|January 27, 2023
Poll: How familiar are you on the approval process for biosimilar drugs in comparison to new drug applications to the FDA?
Author(s)OT Staff Reports
Let us know how familiar are you on the approval process for biosimilar drugs compared with new drug applications to the FDA. The poll will be open until February 28, 2023.
Advertisement
How familiar are you on the approval process for biosimilar drugs in comparison to new drug applications to the FDA?
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR Surgical terminates proposed acquisition by Alcon
2
FDA grants Breakthrough Therapy Designation to Oculis’ privosegtor for optic neuritis
3
Long-lived Greenland sharks may point to new approaches for retinal disease
4
IRIS Registry data mined for understanding of pediatric NK
5












































